PTLD Up for Seronegative Recipients of Epstein-Barr Virus-Seropositive Donor Kidneys
22.1 percent of EBV D+/R− kidney recipients had posttransplant lymphoproliferative disorder at median of 202 days after transplant
FDA Approves Clinical Trials for Pig Kidney Transplants in Humans
FDA Approves Ozempic to Protect Kidneys in Patients With Type 2 Diabetes
Longest Pig Organ Transplant Survivor Passes 60 Days With New Kidney
GLP-1 Receptor Agonists Tied to Risks and Benefits Beyond Weight Loss
Reduced risks seen for neurocognitive, coagulation, cardiometabolic disorders; increased risks seen for GI, arthritic disorders
Tea Consumption Can Lower Mortality in Chronic Kidney Disease
Consuming up to four cups per day associated with lower all-cause mortality among patients with CKD stage 1 to 2
Cancer Mortality Continued to Decline Through 2022
However, increase seen in incidence in women, especially for middle-aged and younger women
Glucarpidase Improves Outcomes in Patients With Methotrexate-Induced Kidney Toxicity
Glucarpidase associated with 2.70-fold increased odds of kidney recovery in methotrexate-acute kidney injury
SPRINT Results Transportable to CKD Patients From Clinical Practice
Associations of intensive versus standard BP control with major cardiovascular events, all-cause death, and adverse events were transportable
Analyses Suggest No Causal Effect of Smoking Behavior on Chronic Kidney Disease
Smoking status, lifetime smoking index positively associated with CKD risk, but no causal association seen in Mendelian randomization analyses
